BioCentury
ARTICLE | Clinical News

Helicoreo and Helicorep: Will begin in the second quarter a Phase I multiple dose trial

February 26, 1996 8:00 AM UTC

Novavax Inc. (NOX), Rockville, Md. Product: Helicoreo and Helicorep Indication: Helicobacter pylori infection Status: Will begin in the second quarter a Phase I multiple dose trial of the two oral ant...